Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to BESSOR PHARMA, LLC in August, 2021 for $1,327,758.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44CA224463-02A1 | Phase II | 1,327,758 | August 12, 2021 | |||||||
A SBIR Phase II contract was awarded to BESSOR PHARMA, LLC in May, 2019 for $849,303.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44DK111251-02A1 | Phase II | 849,303 | May 10, 2019 | |||||||
A SBIR Phase I contract was awarded to BESSOR PHARMA, LLC in May, 2018 for $299,996.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA224463-01 | Phase I | 299,996 | May 2, 2018 | |||||||
A SBIR Phase I contract was awarded to BESSOR PHARMA, LLC in September, 2016 for $300,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK111251-01 | Phase I | 300,000 | September 20, 2016 | |||||||
A STTR Phase I contract was awarded to BESSOR PHARMA, LLC for $219,130.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41CA189537-01 | Phase I | 219,130 | ||||||||
A SBIR Phase I contract was awarded to BESSOR PHARMA, LLC in September, 2023 for $299,999.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI170278-01A1 | Phase I | 299,999 | September 7, 2023 |